These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

135 related items for PubMed ID: 8179303

  • 1. N-acetylgalactosaminyl GD1a is a target molecule for serum antibody in Guillain-Barré syndrome.
    Kusunoki S, Chiba A, Kon K, Ando S, Arisawa K, Tate A, Kanazawa I.
    Ann Neurol; 1994 May; 35(5):570-6. PubMed ID: 8179303
    [Abstract] [Full Text] [Related]

  • 2. Severe acute axonal form of Guillain-Barré syndrome associated with IgG anti-GD1a antibodies.
    Yuki N, Yoshino H, Sato S, Shinozawa K, Miyatake T.
    Muscle Nerve; 1992 Aug; 15(8):899-903. PubMed ID: 1495505
    [Abstract] [Full Text] [Related]

  • 3. [An acute axonal form of Guillain-Barré syndrome with antibodies against gangliosides GM1 and GD1b--a case report].
    Yuki N, Yoshino H, Sato S, Ohno T, Miyatake T.
    Rinsho Shinkeigaku; 1990 Sep; 30(9):989-93. PubMed ID: 2265511
    [Abstract] [Full Text] [Related]

  • 4. Serum antibodies to gangliosides in Guillain-Barré syndrome.
    Ilyas AA, Willison HJ, Quarles RH, Jungalwala FB, Cornblath DR, Trapp BD, Griffin DE, Griffin JW, McKhann GM.
    Ann Neurol; 1988 May; 23(5):440-7. PubMed ID: 3133978
    [Abstract] [Full Text] [Related]

  • 5. GM1/GalNAc-GD1a complex: a target for pure motor Guillain-Barre syndrome.
    Kaida K, Sonoo M, Ogawa G, Kamakura K, Ueda-Sada M, Arita M, Motoyoshi K, Kusunoki S.
    Neurology; 2008 Nov 18; 71(21):1683-90. PubMed ID: 19015484
    [Abstract] [Full Text] [Related]

  • 6. Ganglioside complexes as new target antigens in Guillain-Barré syndrome.
    Kaida K, Morita D, Kanzaki M, Kamakura K, Motoyoshi K, Hirakawa M, Kusunoki S.
    Ann Neurol; 2004 Oct 18; 56(4):567-71. PubMed ID: 15389898
    [Abstract] [Full Text] [Related]

  • 7. Serum antibodies to GM1, GD1b, peripheral nerve myelin, and Campylobacter jejuni in patients with Guillain-Barré syndrome and controls: correlation and prognosis.
    Vriesendorp FJ, Mishu B, Blaser MJ, Koski CL.
    Ann Neurol; 1993 Aug 18; 34(2):130-5. PubMed ID: 8338337
    [Abstract] [Full Text] [Related]

  • 8. Association of IgG anti-GD1a antibody with severe Guillain-Barré syndrome.
    Yuki N, Yamada M, Sato S, Ohama E, Kawase Y, Ikuta F, Miyatake T.
    Muscle Nerve; 1993 Jun 18; 16(6):642-7. PubMed ID: 8502262
    [Abstract] [Full Text] [Related]

  • 9. An antibody to the GM1/GalNAc-GD1a complex correlates with development of pure motor Guillain-Barré syndrome with reversible conduction failure.
    Ogawa G, Kaida K, Kuwahara M, Kimura F, Kamakura K, Kusunoki S.
    J Neuroimmunol; 2013 Jan 15; 254(1-2):141-5. PubMed ID: 23000056
    [Abstract] [Full Text] [Related]

  • 10. [Antiganglioside autoantibody profiles in Guillain-Barré syndrome].
    Caudie C, Vial C, Bancel J, Petiot P, Antoine JC, Gonnaud PM.
    Ann Biol Clin (Paris); 2002 Jan 15; 60(5):589-97. PubMed ID: 12368145
    [Abstract] [Full Text] [Related]

  • 11. Anti-GM1/GD1a complex antibodies in GBS sera specifically recognize the hybrid dimer GM1-GD1a.
    Mauri L, Casellato R, Ciampa MG, Uekusa Y, Kato K, Kaida K, Motoyama M, Kusunoki S, Sonnino S.
    Glycobiology; 2012 Mar 15; 22(3):352-60. PubMed ID: 21921061
    [Abstract] [Full Text] [Related]

  • 12. Antibodies to GT1a ganglioside in patients with Guillain-Barré syndrome.
    Ilyas AA, Cook SD, Mithen FA, Taki T, Kasama T, Handa S, Hamasaki H, Singhal BS, Li SC, Li YT.
    J Neuroimmunol; 1998 Mar 01; 82(2):160-7. PubMed ID: 9585812
    [Abstract] [Full Text] [Related]

  • 13. Ataxic Guillain-Barré syndrome associated with anti-GM1b and anti-GalNAc-GD1a antibodies.
    Odaka M, Yuki N, Tatsumoto M, Tateno M, Hirata K.
    J Neurol; 2004 Jan 01; 251(1):24-9. PubMed ID: 14999485
    [Abstract] [Full Text] [Related]

  • 14. [Axonal Guillain-Barré syndrome associated with antibodies to Ga1NAc-GD1a and unidentified acidic glycolipids].
    Ono M, Sakai T, Ohnishi A, Hashimoto T, Yuki N.
    Rinsho Shinkeigaku; 1997 Feb 01; 37(2):119-22. PubMed ID: 9164143
    [Abstract] [Full Text] [Related]

  • 15. Identification of gangliosides recognized by IgG anti-GalNAc-GD1a antibodies in bovine spinal motor neurons and motor nerves.
    Yoshino H, Ariga T, Suzuki A, Yu RK, Miyatake T.
    Brain Res; 2008 Aug 28; 1227():216-20. PubMed ID: 18598683
    [Abstract] [Full Text] [Related]

  • 16. Spectrum of neurological diseases associated with antibodies to minor gangliosides GM1b and GalNAc-GD1a.
    Tatsumoto M, Koga M, Gilbert M, Odaka M, Hirata K, Kuwabara S, Yuki N.
    J Neuroimmunol; 2006 Aug 28; 177(1-2):201-8. PubMed ID: 16844234
    [Abstract] [Full Text] [Related]

  • 17. N-glycolylneuraminic acid-containing GM1 is a new molecule for serum antibody in Guillain-Barré syndrome.
    Odaka M, Yuki N, Yoshino H, Kasama T, Handa S, Irie F, Hirabayashi Y, Suzuki A, Hirata K.
    Ann Neurol; 1998 Jun 28; 43(6):829-34. PubMed ID: 9629854
    [Abstract] [Full Text] [Related]

  • 18. [Antiganglioside antibodies: when, which and for what].
    Gallardo E, Rojas-García R, Belvís R, Serrano-Munuera C, Ortiz E, Ortiz N, Grau J, Illa I.
    Neurologia; 2001 Jun 28; 16(7):293-7. PubMed ID: 11485721
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.